Wednesday , January 24 2018
Home / Letter From The Editor (page 90)

Letter From The Editor

Letter from Editor ISMP Interview

Every week there is some new headline about patients who have problems with medications. It can be drug interactions, dosing errors, or the wrong medication given. What organization receives error reports, evaluates them, makes sense out of them, and then shares the lessons learned? It is ISMP – the Institute …

Read More »

Letter from the Editor #518

Dear Clinician: If you could make sure all of your patients received diabetes education and extended diabetes management from the first day of diagnosis, would you be interested? If this could be done either in your office or close by, would you be interested? If this could be done with …

Read More »

Letter from the Editor #517

The face of medicine is up for another change this week as the first ARB becomes available generically. Many of our patients have been prevented from getting drugs in this class due to the high cost of the brand names. Now with the approval of generic losartan potassium tablets more …

Read More »

Letter from the Editor #516

This week, the diabetes news included everything from the simple to the complex. On the simple side there were studies showing the value of food choices. Dr. Nancy F. Krebs, professor of pediatrics and head of the division of pediatric nutrition at the University of Colorado, completed a positive successful …

Read More »

Letter from the Editor #515

I was giving a recent talk to some medical professionals and mentioned that our country’s largest export was diabetes. Now there is a new report indicating that China has overtaken both the US and India as the country with the highest number of diabetes patients. (See this week’s Item #14.) …

Read More »

Letter from the Editor #514

I spent a good amount of time in front of the computer this week reading about the new Healthcare bill passed by Congress last weekend. Just when I thought I had it all figured out there were a couple of things that had to be resolved by the House and …

Read More »

Letter from the Editor #513

Thanks to all of you who stopped and visited with us at our booth at the APhA annual meeting in Washington last week. Many of you were very focused on learning more about diabetes care and how you could work with other clinicians to help manage patients. As I wandered …

Read More »

Letter from the Editor #512

March 15, 2010 — SPECIAL NEWSFLASH!: Amylin, Lilly and Alkermes received a Complete Response Letter from FDA for Exenatide Once Weekly. New drug to be called BYDUREON (exenatide for extended-release injectable suspension). For more information, click on this link: Exenatide Once Weekly FDA Update *************************************************************** Steve, Andrew and I are …

Read More »

Letter from the Editor #511

Obesity and weight control in our patients continues to be big news each and every week. The new issue of the ADA magazine, “Diabetes Forecast,” has an 8 page spread on surgery for weight loss. The article does a great job of showing the benefits versus the risks of bariatric surgery. …

Read More »

Letter from the Editor #510

It appears that the FDA and Congress are trying to deal a final blow to GSK’s Avandia. The legislators have spent hundreds of hours reviewing tons of research and have decided that GSK withheld info about the potential for problems. (See Item #1.) To their credit GSK has decided to …

Read More »